Pharmaceuticals - , Chubut Province, Argentina
Debiopharm Research & Manufacturing SA (formerly Debio R.P. SA) is a pharmaceutical research, development and production facility that is Swissmedic and ANVISA (Brazil) certified as well as FDA (American Food and Drug Administration) inspected and registered. The Company, a world leader in polylactic-co-glycolic acid (PLGA)-based injectable, sustained-release technology, achieved prominence in 1986 with the launch of the drug Decapeptyl®, a novel injectable controlled-release formulation of triptorelin - a gonadotropin releasing hormone (GnRH) agonist analogue.This mode of administration developed by Debio R.P. relies on the active substance being "encapsulated" in a PLGA polymer to allow gradual dissolution and distribution of the substance in the patient's body.